nodes	percent_of_prediction	percent_of_DWPC	metapath
Glisoxepide—KCNJ8—adrenal cortex—polycystic ovary syndrome	0.0618	0.0913	CbGeAlD
Glisoxepide—KCNJ8—endometrium—polycystic ovary syndrome	0.0552	0.0815	CbGeAlD
Glisoxepide—KCNJ8—uterus—polycystic ovary syndrome	0.0509	0.0751	CbGeAlD
Glisoxepide—KCNJ8—pituitary gland—polycystic ovary syndrome	0.05	0.0738	CbGeAlD
Glisoxepide—KCNJ8—adipose tissue—polycystic ovary syndrome	0.0497	0.0735	CbGeAlD
Glisoxepide—KCNJ8—adrenal gland—polycystic ovary syndrome	0.0446	0.0659	CbGeAlD
Glisoxepide—KCNJ8—female gonad—polycystic ovary syndrome	0.0416	0.0615	CbGeAlD
Glisoxepide—ABCC8—endometrium—polycystic ovary syndrome	0.0414	0.0612	CbGeAlD
Glisoxepide—KCNJ8—vagina—polycystic ovary syndrome	0.0414	0.0611	CbGeAlD
Glisoxepide—KCNJ8—endocrine gland—polycystic ovary syndrome	0.0387	0.0572	CbGeAlD
Glisoxepide—ABCC8—pituitary gland—polycystic ovary syndrome	0.0375	0.0554	CbGeAlD
Glisoxepide—KCNJ11—adrenal gland—polycystic ovary syndrome	0.0364	0.0537	CbGeAlD
Glisoxepide—ABCC8—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.0357	0.127	CbGpPWpGaD
Glisoxepide—KCNJ11—female gonad—polycystic ovary syndrome	0.0339	0.0501	CbGeAlD
Glisoxepide—ABCC8—adrenal gland—polycystic ovary syndrome	0.0335	0.0495	CbGeAlD
Glisoxepide—KCNJ11—endocrine gland—polycystic ovary syndrome	0.0315	0.0466	CbGeAlD
Glisoxepide—KCNJ11—Type II diabetes mellitus—INS-IGF2—polycystic ovary syndrome	0.0295	0.105	CbGpPWpGaD
Glisoxepide—ABCC8—endocrine gland—polycystic ovary syndrome	0.029	0.0429	CbGeAlD
Glisoxepide—Gliclazide—VEGFA—polycystic ovary syndrome	0.0238	0.565	CrCbGaD
Glisoxepide—Glipizide—PPARG—polycystic ovary syndrome	0.0183	0.435	CrCbGaD
Glisoxepide—KCNJ11—Type II diabetes mellitus—INSR—polycystic ovary syndrome	0.0149	0.0532	CbGpPWpGaD
Glisoxepide—KCNJ11—Type II diabetes mellitus—ADIPOQ—polycystic ovary syndrome	0.0124	0.0443	CbGpPWpGaD
Glisoxepide—KCNJ11—Type II diabetes mellitus—SLC2A4—polycystic ovary syndrome	0.0118	0.0419	CbGpPWpGaD
Glisoxepide—ABCC8—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.0103	0.0367	CbGpPWpGaD
Glisoxepide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.00999	0.0356	CbGpPWpGaD
Glisoxepide—KCNJ8—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00838	0.0299	CbGpPWpGaD
Glisoxepide—ABCC8—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.00819	0.0292	CbGpPWpGaD
Glisoxepide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.00794	0.0283	CbGpPWpGaD
Glisoxepide—KCNJ11—Type II diabetes mellitus—IRS1—polycystic ovary syndrome	0.0069	0.0246	CbGpPWpGaD
Glisoxepide—KCNJ8—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00532	0.019	CbGpPWpGaD
Glisoxepide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NR3C1—polycystic ovary syndrome	0.00515	0.0183	CbGpPWpGaD
Glisoxepide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NR3C1—polycystic ovary syndrome	0.00499	0.0178	CbGpPWpGaD
Glisoxepide—KCNJ8—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00474	0.0169	CbGpPWpGaD
Glisoxepide—KCNJ8—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00392	0.014	CbGpPWpGaD
Glisoxepide—ABCC8—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.00391	0.0139	CbGpPWpGaD
Glisoxepide—KCNJ8—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00383	0.0136	CbGpPWpGaD
Glisoxepide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.00379	0.0135	CbGpPWpGaD
Glisoxepide—ABCC8—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00373	0.0133	CbGpPWpGaD
Glisoxepide—ABCC8—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.00373	0.0133	CbGpPWpGaD
Glisoxepide—KCNJ11—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.00362	0.0129	CbGpPWpGaD
Glisoxepide—KCNJ8—Neuronal System—DLG4—polycystic ovary syndrome	0.00347	0.0124	CbGpPWpGaD
Glisoxepide—ABCC8—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.00294	0.0105	CbGpPWpGaD
Glisoxepide—KCNJ11—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.00285	0.0101	CbGpPWpGaD
Glisoxepide—ABCC8—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00266	0.00948	CbGpPWpGaD
Glisoxepide—ABCC8—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.0025	0.0089	CbGpPWpGaD
Glisoxepide—KCNJ11—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.00242	0.00863	CbGpPWpGaD
Glisoxepide—ABCC8—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00241	0.00857	CbGpPWpGaD
Glisoxepide—ABCC8—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00197	0.007	CbGpPWpGaD
Glisoxepide—ABCC8—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00192	0.00683	CbGpPWpGaD
Glisoxepide—KCNJ11—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00191	0.00679	CbGpPWpGaD
Glisoxepide—KCNJ11—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00186	0.00662	CbGpPWpGaD
Glisoxepide—KCNJ8—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00184	0.00655	CbGpPWpGaD
Glisoxepide—ABCC8—Neuronal System—DLG4—polycystic ovary syndrome	0.00169	0.00604	CbGpPWpGaD
Glisoxepide—KCNJ11—Neuronal System—DLG4—polycystic ovary syndrome	0.00164	0.00585	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—NMNAT3—polycystic ovary syndrome	0.00156	0.00555	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—NMNAT3—polycystic ovary syndrome	0.00151	0.00538	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—LPCAT2—polycystic ovary syndrome	0.00143	0.00508	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—SUOX—polycystic ovary syndrome	0.00143	0.00508	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—SUOX—polycystic ovary syndrome	0.00138	0.00492	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—LPCAT2—polycystic ovary syndrome	0.00138	0.00492	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—ISYNA1—polycystic ovary syndrome	0.00133	0.00472	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—ISYNA1—polycystic ovary syndrome	0.00129	0.00458	CbGpPWpGaD
Glisoxepide—KCNJ8—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00127	0.00453	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—AKR1C2—polycystic ovary syndrome	0.00113	0.00401	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—TEAD2—polycystic ovary syndrome	0.00113	0.00401	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—TEAD2—polycystic ovary syndrome	0.00109	0.00389	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—AKR1C2—polycystic ovary syndrome	0.00109	0.00389	CbGpPWpGaD
Glisoxepide—ABCC8—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.001	0.00358	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000945	0.00336	CbGpPWpGaD
Glisoxepide—ABCC8—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000934	0.00333	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—PNPLA2—polycystic ovary syndrome	0.000916	0.00326	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000895	0.00319	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—SRD5A1—polycystic ovary syndrome	0.000868	0.00309	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—STAR—polycystic ovary syndrome	0.000854	0.00304	CbGpPWpGaD
Glisoxepide—ABCC8—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000854	0.00304	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—STAR—polycystic ovary syndrome	0.000828	0.00295	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—HMMR—polycystic ovary syndrome	0.000761	0.00271	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—HMMR—polycystic ovary syndrome	0.000738	0.00263	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000726	0.00259	CbGpPWpGaD
Glisoxepide—ABCC8—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000717	0.00255	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—HSD3B1—polycystic ovary syndrome	0.000704	0.00251	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—LHB—polycystic ovary syndrome	0.000662	0.00236	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—HSD3B2—polycystic ovary syndrome	0.000647	0.00231	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—LHB—polycystic ovary syndrome	0.000642	0.00229	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—HSD3B2—polycystic ovary syndrome	0.000628	0.00224	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—AKR1C1—polycystic ovary syndrome	0.000627	0.00223	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—AKR1C1—polycystic ovary syndrome	0.000608	0.00217	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—SULT2A1—polycystic ovary syndrome	0.000577	0.00206	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—SULT2A1—polycystic ovary syndrome	0.00056	0.00199	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—RRM2—polycystic ovary syndrome	0.000559	0.00199	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—RRM2—polycystic ovary syndrome	0.000542	0.00193	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—YAP1—polycystic ovary syndrome	0.000539	0.00192	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—YAP1—polycystic ovary syndrome	0.000522	0.00186	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—NAMPT—polycystic ovary syndrome	0.000518	0.00184	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—CYP11A1—polycystic ovary syndrome	0.000511	0.00182	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—NAMPT—polycystic ovary syndrome	0.000502	0.00179	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—CYP11A1—polycystic ovary syndrome	0.000496	0.00177	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—AKR1C3—polycystic ovary syndrome	0.000483	0.00172	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—CYP17A1—polycystic ovary syndrome	0.000475	0.00169	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—AKR1C3—polycystic ovary syndrome	0.000468	0.00167	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—CYP17A1—polycystic ovary syndrome	0.000461	0.00164	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—TH—polycystic ovary syndrome	0.000411	0.00146	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—SLC2A4—polycystic ovary syndrome	0.0004	0.00142	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—TH—polycystic ovary syndrome	0.000399	0.00142	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—SLC2A4—polycystic ovary syndrome	0.000388	0.00138	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—CYP19A1—polycystic ovary syndrome	0.000376	0.00134	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—CYP19A1—polycystic ovary syndrome	0.000365	0.0013	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—GNAS—polycystic ovary syndrome	0.000336	0.0012	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—GNAS—polycystic ovary syndrome	0.000325	0.00116	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—NCOR1—polycystic ovary syndrome	0.00032	0.00114	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—NCOR1—polycystic ovary syndrome	0.00031	0.0011	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—CYP1A1—polycystic ovary syndrome	0.000303	0.00108	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—CYP1A1—polycystic ovary syndrome	0.000294	0.00105	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—MTHFR—polycystic ovary syndrome	0.000283	0.00101	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—MTHFR—polycystic ovary syndrome	0.000274	0.000976	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—PPARG—polycystic ovary syndrome	0.000229	0.000816	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—POMC—polycystic ovary syndrome	0.000226	0.000805	CbGpPWpGaD
Glisoxepide—ABCC8—Metabolism—INS—polycystic ovary syndrome	0.000225	0.0008	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—PPARG—polycystic ovary syndrome	0.000222	0.000791	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—POMC—polycystic ovary syndrome	0.000219	0.000781	CbGpPWpGaD
Glisoxepide—KCNJ11—Metabolism—INS—polycystic ovary syndrome	0.000218	0.000776	CbGpPWpGaD
